Replies to post #80815 on Amarin Corp Plc (AMRN)

[HDGabor]

M-

It won't be an "ambiguous result". It will be a failure (especially due to low Power of 7% RRR).

Best,
G

[Whalatane]

Mog In the scenario you laid out in that post
Vascepa shows only a 7% decrease in events etc ...Kaiser would probably not cover and tell all CAD patients to take high quality DS alternative.

Some Health Co's ..Federal Blue Cross/Blue Shield programs etc may still continue coverage as they do now ...so AMRN would have the Marine indication covered and limited CAD coverage ...so my guess is that the stock would be between $1-$3.

In other words ...where it is now.

So anything better then that is an upside surprise.

As long as script numbers continue to trend upwards on a rolling 4 wk basis ...can you see any reason for AMRN to drop below $1.20 ?
Kiwi